Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Short-term Investments (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Short-term Investments for 2 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • Quarterly Short-term Investments changed 0.0% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $1.5 million for FY2025, 0.0% changed from the prior year.
  • Short-term Investments for Q4 2025 was $1.5 million at Pyxis Oncology, roughly flat from $1.5 million in the prior quarter.
  • The five-year high for Short-term Investments was $129.1 million in Q1 2024, with the low at $1.5 million in Q2 2024.